Financial Data and Key Metrics Changes - The company reported revenues before reimbursements of $77.6 million, an increase of 2% over the prior year, which was above the high end of quarterly guidance [15] - Adjusted earnings per share were $0.38, at the midpoint of the earnings guidance range, compared to $0.39 in the prior year [20] - GAAP net income totaled $1.7 million, or diluted earnings per share of $0.06, down from $8.7 million or $0.31 in the previous year [19] - Adjusted gross margin was 42.8%, compared to 42.3% in the prior quarter [18] - Days sales outstanding (DSO) remained at 73 days, compared to 68 days from the prior year [21] Business Line Data and Key Metrics Changes - The Global S and BT segment reported revenues of $43.6 million, a 5% increase year-over-year, with GenAI consulting and implementation offerings driving growth [15][16] - The Oracle Solutions segment saw revenues decrease by 7.5% to $20.5 million, primarily due to the wind-down of a large engagement [17] - The SAP Solutions segment reported revenues of $13.5 million, an increase of 11% year-over-year, driven by increased software sales activity [17] - Excluding the OneStream practice, the GSBT segment was up 10% [7] Market Data and Key Metrics Changes - Approximately 21% of total revenues consist of recurring multiyear and subscription-based revenues [17] - The company expects global S and BT and SAP Solutions segment revenue to increase compared to the prior year, while Oracle Solutions segment revenue is expected to decline by over 20% [23] Company Strategy and Development Direction - The company is focusing on Generative AI (GenAI) solutions, viewing it as a generational opportunity that will change consulting services delivery [8][27] - A strategic partnership with Salonis was announced to enhance AI Explorer and ZBrain capabilities, aiming to accelerate growth in the GenAI space [6][41] - The company is investing in its AI Explorer platform, with a new version expected to significantly enhance its capabilities [30] - The acquisition of Leeway Hertz is aimed at expanding GenAI implementation capabilities [27] Management's Comments on Operating Environment and Future Outlook - Management noted that while demand for digital transformation remains strong, it is impacted by economic concerns and decision-making processes [26] - IT budgets are expected to increase, particularly for GenAI initiatives, which are seen as high-impact areas [26] - The company anticipates restructuring charges in Q3 due to adjustments in headcount to align with GenAI productivity improvements [23] Other Important Information - The company repurchased 180,000 shares at an average price of $24.5 per share, totaling approximately $4.4 million [22] - The board declared a third-quarter dividend of $0.12 per share [22] Q&A Session Summary Question: Discussion on Explorer 3.0 and interest levels - Management indicated that while services related to AI Explorer are seeing interest, licensing for the product has not yet been released due to ongoing improvements [36][37] Question: Status of strategic partnerships - A strategic alliance with Salonis was announced, which is expected to enhance market offerings [41][42] Question: Oracle segment challenges - Management acknowledged challenges in replacing a large engagement in the Oracle segment, impacting Q2 results and expected to continue into Q3 [44] Question: OneStream performance outlook - Management expects the impact from OneStream to decrease significantly in Q4, providing a cleaner comparison [48] Question: Examples of GenAI applications - Key areas of focus include customer service and revenue management, with significant engagement from clients in these areas [49] Question: Clarity on elevated uncertainty affecting client decisions - Management believes initial uncertainties had little impact on Q2, with expectations for demand to increase as clients understand GenAI's potential [51]

Financial Data and Key Metrics Changes - Total revenue for the first quarter of 2025 was $77.9 million, up 1% year-over-year, with revenues before reimbursements at $76.2 million, also up 1% [15][22] - Adjusted earnings per share were $0.41, at the high end of quarterly guidance, compared to $0.39 in the prior year [6][22] - GAAP net income for Q1 2025 was $3.1 million or diluted earnings per share of $0.11, down from $8.7 million or $0.32 in the previous year [20][22] - Adjusted gross margin improved to 43.4% from 41.4% year-over-year, driven by higher margin GenAI consulting and implementation revenue [19] Business Line Data and Key Metrics Changes - Global SMBT segment revenues were $43.4 million, with revenues before reimbursements at $42.6 million, a 6% increase year-over-year [15][16] - Oracle Solutions segment revenues were $21.1 million, with revenues before reimbursements down 3% year-over-year [16] - SAP Solutions segment revenues were $13.4 million, with revenues before reimbursements down 8% year-over-year, but expected to improve due to increased software sales [17] Market Data and Key Metrics Changes - Approximately 23% of total revenues before reimbursements were recurring, multi-year, and subscription-based revenues [18] - Days sales outstanding (DSO) increased to 73 days from 66 days in the previous quarter, attributed to extended terms on large client engagements [22] Company Strategy and Development Direction - The company is focusing on GenAI enabled transformations, viewing it as a generational opportunity that will change consulting services delivery [7][26] - The acquisition of Leeway Hertz and the development of the ZBrain platform are strategic moves to enhance GenAI capabilities [28][29] - The company plans to leverage its AI Explorer platform to integrate GenAI capabilities across all offerings, enhancing its competitive position [31][32] Management's Comments on Operating Environment and Future Outlook - Management noted that while demand for digital transformation remains strong, economic uncertainties and tariff negotiations could impact client decision-making [25][48] - The company expects IT budgets to increase, particularly for GenAI initiatives, with a shift from awareness to budgeted projects [25][26] - Management anticipates continued growth in GenAI revenue, with licensing revenues expected to start in July 2025 [51] Other Important Information - The company repurchased 379,000 shares at an average price of $30.93, totaling approximately $11.7 million [23] - A second-quarter dividend of $0.12 per share was declared, payable on July 7, 2025 [23] Q&A Session Summary Question: Can you elaborate on client interactions with AI Explorer and the pipeline for implementation projects? - Management highlighted unique capabilities in ideation and evaluation, leading to favorable client reactions and new engagements [38][39] Question: What is the current capacity for AI implementation and plans for scaling? - Management indicated a 60% to 70% increase in capacity since acquisitions, with ongoing hiring to expand resources [42][43] Question: What is the progress of the joint venture with ZBrain? - Management confirmed the addition of licensed clients to the ZBrain platform and expected to finalize the JV agreement soon [44] Question: How does economic disruption impact the business? - Management acknowledged the potential for clients to pause decisions due to economic concerns but noted strong engagement in GenAI capabilities [48][49] Question: What is the expected impact of GenAI on 2025 results? - Management expects meaningful growth in ARR and licensing revenues, with a focus on channel partnerships to enhance distribution [50][53] Question: What portion of AI revenue was implementation revenue in the quarter? - Management estimated a 50-50 split between implementation and ideation revenue, with expectations for implementation to grow significantly [61] Question: How is the pipeline looking for Oracle? - Management indicated that Oracle's activity is expected to be down, while SAP's momentum is improving [64]

Financial Data and Key Metrics Changes - The company reported total revenue of $77.9 million, up 1% year-over-year, with revenues before reimbursements at $76.2 million, also up 1% [13] - Adjusted earnings per share were $0.41, at the high end of quarterly guidance, compared to $0.39 in the prior year [19] - GAAP net income for the quarter was $3.1 million, or diluted earnings per share of $0.11, down from $8.7 million or $0.32 in the previous year [18] - Adjusted gross margin improved to 43.4% from 41.4% in the prior year, driven by higher margin GenAI consulting and implementation revenue [17] Business Line Data and Key Metrics Changes - The Global SMBT segment revenues were $43.4 million, with revenues before reimbursements at $42.6 million, a 6% increase year-over-year [13] - The Oracle Solutions segment saw revenues of $21.1 million, down 3% year-over-year, primarily due to the wind down of a large engagement [14] - The SAP Solutions segment reported revenues of $13.4 million, down 8% year-over-year, but expected to see strong demand due to increased software sales [15] Market Data and Key Metrics Changes - Approximately 23% of total revenues before reimbursements consist of recurring, multi-year, and subscription-based revenues [16] - Days Sales Outstanding (DSO) increased to 73 days from 66 days in the previous quarter, attributed to extended terms on large client engagements [20] Company Strategy and Development Direction - The company is focusing on GenAI enabled transformations, viewing it as a generational opportunity that will change consulting services delivery [6][24] - The acquisition of Leeway Hertz and the integration of ZBrain are expected to enhance the company's capabilities in GenAI solutions [25][27] - The company plans to leverage its AI Explorer platform to integrate GenAI capabilities across all offerings, enhancing its market position [29][30] Management's Comments on Operating Environment and Future Outlook - Management noted that while demand for digital transformation remains strong, economic concerns and tariff negotiations may impact client decision-making [23] - The company expects IT budgets to increase, with a focus on GenAI initiatives in high feasibility areas [24] - Management anticipates continued growth in GenAI revenue, with licensing expected to start in July [49] Other Important Information - The company repurchased 379,000 shares at an average price of $30.93, totaling approximately $11.7 million [21] - A second quarter dividend of $0.12 per share was declared, payable on July 7, 2025 [21] Q&A Session Summary Question: Can you elaborate on client interactions with AI Explorer and the pipeline for implementation projects? - Management highlighted unique capabilities in ideation and evaluation, leading to favorable client reactions and new engagements [35][36] Question: What is the current capacity for AI implementation and plans for scaling further? - Management indicated a 60% to 70% increase in capacity since acquisitions, with ongoing hiring to expand resources [39] Question: Update on the joint venture with ZBrain and any ARR contracts? - Management confirmed the addition of licensed clients to the ZBrain platform and expected to finalize the JV agreement soon [40] Question: How does economic disruption impact the business model? - Management acknowledged the need to address strategic cost reduction and efficiency in light of economic disruptions [44] Question: What is the expected impact of GenAI on 2025 results? - Management expects meaningful growth in GenAI revenue and licensing, with potential for accelerated growth through the JV [47][49] Question: What portion of AI revenue was implementation revenue in the quarter? - Management estimated a 50-50 split between implementation and discovery ideation revenue, with expectations for implementation to grow significantly [59] Question: Are you seeing cross-selling from GenAI consulting clients into other services? - Management confirmed cross-selling opportunities, integrating GenAI solutions into traditional digital transformation engagements [60]